T1	Participants 435 617	Sixty-six consecutive patients from two RT clinics in Sweden were randomised into one of two groups: training with TheraBite(®) Jaw Motion Rehabilitation System(™) or a control group
T2	Participants 343 425	patients with head and neck cancer (HNC), also investigating the incidence of RTIT
